First Trust Advisors’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-7,668
| Closed | -$612K | – | 2588 |
|
|
2021
Q1 | $612K | Sell |
7,668
-1,509
| -16% | -$118K | ﹤0.01% | 2152 |
|
|
2020
Q4 | $724K | Sell |
9,177
-5,456
| -37% | -$320K | ﹤0.01% | 2018 |
|
|
2020
Q3 | $643K | Buy |
14,633
+9,154
| +167% | +$451K | ﹤0.01% | 1942 |
|
|
2020
Q2 | $242K | Buy |
+5,479
| New | +$204K | ﹤0.01% | 2199 |
|
|
2020
Q1 | – | Sell |
-58,965
| Closed | -$4.18M | – | 2452 |
|
|
2019
Q4 | $4.18M | Sell |
58,965
-20,804
| -26% | -$1.51M | 0.01% | 1178 |
|
|
2019
Q3 | $5.97M | Buy |
+79,769
| New | +$6.76M | 0.01% | 994 |
|
|
2019
Q2 | – | Sell |
-6,887
| Closed | -$461K | – | 2547 |
|
|
2019
Q1 | $461K | Buy |
+6,887
| New | +$522K | ﹤0.01% | 2155 |
|
|
2018
Q4 | – | Sell |
-12,335
| Closed | -$1.14M | – | 2514 |
|
|
2018
Q3 | $1.14M | Sell |
12,335
-22,130
| -64% | -$2.11M | ﹤0.01% | 1916 |
|
|
2018
Q2 | $3.39M | Buy |
34,465
+6,387
| +23% | +$714K | 0.01% | 1314 |
|
|
2018
Q1 | $3.13M | Sell |
28,078
-3,596
| -11% | -$403K | 0.01% | 1216 |
|
|
2017
Q4 | $3.26M | Buy |
31,674
+19,997
| +171% | +$1.99M | 0.01% | 1223 |
|
|
2017
Q3 | $1.1M | Buy |
11,677
+739
| +7% | +$58.3K | ﹤0.01% | 1816 |
|
|
2017
Q2 | $852K | Sell |
10,938
-17,743
| -62% | -$1.33M | ﹤0.01% | 1906 |
|
|
2017
Q1 | $2.3M | Sell |
28,681
-4,522
| -14% | -$359K | 0.01% | 1406 |
|
|
2016
Q4 | $2.62M | Buy |
33,203
+5,623
| +20% | +$437K | 0.01% | 1279 |
|
|
2016
Q3 | $2.15M | Sell |
27,580
-20,935
| -43% | -$1.52M | 0.01% | 1295 |
|
|
2016
Q2 | $3.33M | Buy |
48,515
+20,926
| +76% | +$1.44M | 0.01% | 1063 |
|
|
2016
Q1 | $1.97M | Sell |
27,589
-33,844
| -55% | -$2.12M | 0.01% | 1315 |
|
|
2015
Q4 | $3.82M | Buy |
61,433
+1,752
| +3% | +$107K | 0.01% | 1076 |
|
|
2015
Q3 | $3.38M | Buy |
59,681
+1,102
| +2% | +$58.4K | 0.01% | 1126 |
|
|
2015
Q2 | $3.14M | Buy |
58,579
+3,707
| +7% | +$180K | 0.01% | 1263 |
|
|
2015
Q1 | $2.61M | Buy |
54,872
+11,243
| +26% | +$498K | 0.01% | 1346 |
|
|
2014
Q4 | $1.89M | Sell |
43,629
-12,750
| -23% | -$521K | 0.01% | 1477 |
|
|
2014
Q3 | $1.94M | Buy |
56,379
+27,193
| +93% | +$960K | 0.01% | 1398 |
|
|
2014
Q2 | $1.07M | Sell |
29,186
-13,371
| -31% | -$454K | ﹤0.01% | 1658 |
|
|
2014
Q1 | $1.44M | Sell |
42,557
-18,652
| -30% | -$615K | 0.01% | 1541 |
|
|
2013
Q4 | $2.08M | Buy |
61,209
+37,321
| +156% | +$1.29M | 0.01% | 1325 |
|
|
2013
Q3 | $761K | Buy |
23,888
+13,544
| +131% | +$360K | ﹤0.01% | 1691 |
|
|
2013
Q2 | $234K | Buy |
+10,344
| New | +$224K | ﹤0.01% | 2110 |
|
First Trust Advisors's CMD Position: Q2 2021 in Review
First Trust Advisors sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 7,668 shares — an estimated $612K sold.
First Trust Advisors first reported a position in CMD in Q2 2013 and held it in 29 quarters. The position peaked at $5.97M in Q3 2019. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- First Trust Advisors reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- First Trust Advisors sold 7,668 Cantel Medical Corporation shares in Q2 2021, an estimated $612K.
- First Trust Advisors first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 29 quarters.
- First Trust Advisors's Cantel Medical Corporation position peaked at $5.97M in Q3 2019.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on First Trust Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.